Error: Could not add to watchlist. X

Opexa Therapeutics Inc

+ Watchlist
P6N:GR
Ticker Change
P6N:GR has changed to a new ticker symbol
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Opexa Therapeutics, Inc. is biotechnology company. The company develops cellular therapies for the treatment of multiple sclerosis, rheumatoid arthritis, pancreatic, and cardiac conditions. Opexa holds a worldwide license for an autologous T cell vaccine for rheumatoid arthritis.
ADDRESS
2635 Technology Forest Blvd
The Woodlands, TX 77381
United States
PHONE
1-281-272-9331
  • Neil K Warma
    President/CEO
  • Karthik Radhakrishnan
    Chief Financial Officer
  • Donna R Rill
    Chief Development Officer
  • Jason Kralic
    VP:Business Development
Show More